TOX2 and neoplasm: TOX2 was recently reported to be a novel tumor driver in natural killer/T-cell lymphoma (NKTL) [24] and high expression of TOX2 was associated with worse overall survival in both NKTL and acute myeloid leukemia (AML) [24, 41].